-
immunogenicity. Over the past decade, this process has been well characterized, and robust methods have been developed to predict it with high confidence. In contrast, our understanding of the principles governing
-
designed to prepare postdoctoral researchers for a successful ERC Starting Grant application or equivalent and for an independent research career in top research organisations in Europe and around the
-
these therapeutics to the right organ with the right dose. Our research performance involves developing novel and innovative drug delivery technologies that can carry proteins, RNAs, or gene editors to the target
-
accepted from February 10, Tuesday, to April 9, Thursday, 2026. Inquiry: SPDR Desk, Research Personnel Development Section, RIKEN 2-1 Hirosawa, Wako, Saitama 351-0198 Japan Email: wakate@ml.riken.jp